This MedLibrary.org supplementary page on Imperial Chemical Industries is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed. (June 2007) |
 |
|
| Type | Subsidiary |
|---|---|
| Founded | 1926 |
| Headquarters | Slough, England, UK |
| Key people | Peter Ellwood (Chairman) John McAdam (CEO) |
| Industry | Chemicals |
| Products | Paints & speciality chemicals |
| Revenue | £4,845 million GBP (2006) |
| Operating income | £502 million GBP (2006) |
| Net income | £295 million GBP (2006) |
| Owner | Akzo Nobel |
| Employees | 29,130 (2006) |
| Website | www.ici.com |
Imperial Chemical Industries (ICI) is a British chemical subsidiary of a Dutch conglomerate and one of the largest chemical producers in the world. It is based in Slough[1], UK. It produces paints and speciality products (including ingredients for foods, specialty polymers, electronic materials, fragrances and flavours). It employs around 29,000 people and had a turnover of just over £4.8 billion in 2006. Since January 2008, ICI has been a subsidiary of Dutch chemicals group Akzo Nobel,[2] which is in the process of fully integrating the two companies.[3]
Contents |
History
Formation
ICI was founded in December 1926 from the merger of four companies—Brunner Mond, Nobel Explosives, the United Alkali Company, and British Dyestuffs Corporation.
Competing with DuPont and IG Farben (which was subsequently split up in 1952 into BASF, Agfa, Hoechst AG, Bayer and other companies), the new company produced explosives, fertilisers, insecticides, dyestuffs, industrial chemicals, printing materials, and paints. In its first year turnover was £27m.
Until 1937, the Sunbeam motorcycle business, which had come with Nobel Industries, was part of ICI.
Significant products
ICI played a key role in the development of new products, including the dyestuff phthalocyanine (1929), the acrylic plastic Perspex (1932), Dulux paints (1932, co-developed with DuPont), polyethylene (1937), Polyethylene terephthalate fibre known as Terylene (1941), sulfamethazine (the first sulfonamide antibiotic), paludrine (1940s, an anti-malarial drug), halothane (1951, an anaesthetic agent), Inderal (1965, a beta-blocker), brodifacoum (a rodenticide) in 1974, tamoxifen (1978, a frequently used drug for breast cancer), and PEEK (1979, a high performance thermoplastic). Because of their success in the pharmaceutical industry, ICI formed ICI Pharmaceuticals in 1957. The company is now part of the AstraZeneca group.
However, ICI made several mistakes in developing new materials, such as Biopol, a bioengineered plastic. Its properties were poor, and the cost of production very high, so the pilot plant on Teesside was closed in the early 1990's.
Main sites
ICI operated a number of chemical sites around the world. In the UK the main plants were situated at Billingham and Wilton (on Teesside) and Runcorn (in Cheshire). The Runcorn site was responsible for the development of the HiGEE and Spinning Disc Reactor concepts which were developed by Prof Colin Ramshaw, which lead to the concept of Process Intensification. Research into these novel technologies is currently being pursued by the Process Intensification Group at Newcastle University
Unsuccessful Hanson takeover
In 1988, the company successfully fought off a hostile takeover bid from the Hanson plc conglomerate.
1990 demergers
In 1993 the company decided to demerge its chemical business from the pharmaceutical bioscience divisions. Pharmaceuticals, agrochemicals, specialities, seeds and biological products were placed into a new and independent company called Zeneca Group (which merged with Astra AB in 1999 to form AstraZeneca PLC, one of the largest pharmaceutical companies in the world). The company also moved away from bulk and industrial chemicals towards speciality chemicals during the 1990s in the hope of making its income less dependent on the business cycle, earning higher profit margins, and developing businesses with long term growth potential. However its financial performance so far in the 21st century has been erratic.
ICI sold its Australian subsidiary, ICI Australia, in 1997 and the following year the former subsidiary changed its name to Orica.
Akzo Nobel takeover
Dutch firm Akzo Nobel (owner of Crown Berger paints) bid £7.2 billion (€10.66 billion or $14.5 billion US) for ICI in June 2007. An area of concern about a potential deal was ICI's British pension fund, which had future liabilities of more than £9 billion at the time.[4] Regulatory issues in the UK and other markets where Dulux and Crown Paints brands each have significant market share were also a cause for concern for the boards of ICI and Akzo Nobel. In the UK, any combined operation without divestments would have seen Akzo Nobel have a 54% market share in the paint market.[5] The initial bid was rejected by the ICI board and the majority of shareholders.[6] However, a subsequent bid for £8 billion (€11.82 billion) was accepted by ICI in August 2007, pending approval by regulators.[7]
As of 8.00am on 2 January 2008 ICI PLC became a subsidiary of Akzo Nobel NV.[2] Shareholders of ICI will receive either £6.70 in cash or Akzo Nobel loan notes to the value of £6.70 per 1 nominal ICI share. The adhesives business of ICI has been transferred to Henkel as a result of the deal,[8] while Akzo has agreed to sell its Crown Paints subsidiary to satisfy the concerns of the European Commissioner for Competition.[9]
The areas of concern regarding the ICI UK pension scheme have been addressed by ICI and Akzo.[10]
References
- ^ http://www.ici.com/aboutus/CompanyOverview/Paints
- ^ a b "Akzo Nobel ICI merger completed", BBC News (2008-01-02). Retrieved on 2008-01-05.
- ^ Akzo Nobel U.K. (7 January 2008). "Akzo Nobel to Focus on Fast and Effective Integration in 2008". Press release. Retrieved on 2008-02-13.
- ^ "Dutch poised to clinch £8bn ICI takeover", The Times (2007-08-05). Retrieved on 2008-01-05.
- ^ "ICI snubs second offer from Akzo", BBC News (2007-07-30). Retrieved on 2007-07-30.
- ^ "ICI rejects £7.2bn bid approach", BBC News (2007-06-18). Retrieved on 2008-01-05.
- ^ "ICI agrees to be bought by Akzo", BBC News (2007-08-13). Retrieved on 2007-08-13.
- ^ "Henkel to pay $5.5 bln for ICI units: Akzo", Reuters (2007-08-06). Retrieved on 2008-01-05.
- ^ "Akzo Nobel to sell Crown paints", BBC News (2007-12-14). Retrieved on 2008-01-05.
- ^ ICI Pension Fund Web Site.
External links
- Official site
- Dulux
- National Starch and Chemical Company ICI subsidiary.
- Yahoo! profile
- Orica
|
|||||
|
|||||
Wikipedia content modification information:
- This page was last modified on 4 October 2008, at 21:52.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Imperial Chemical Industries".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.